Shares in Qiagen and Waters hit 52-week highs this week as their shares closed the 5-day trading period up 5.9 percent and 7.65 percent, respectively. Qiagen reached a year-long high of $16.55 on Tuesday before closing at $16.52, while Waters hit a high of $55.57 before closing Tuesday at $55.05.
 
Molecular Devices led all gainers in the BCW Index, closing up 9.74 percent for the tracking period. Sequenom led decliners with a drop of 13.24 percent for the week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.